1. Home
  2. AQMS vs INTS Comparison

AQMS vs INTS Comparison

Compare AQMS & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aqua Metals Inc.

AQMS

Aqua Metals Inc.

HOLD

Current Price

$5.49

Market Cap

12.8M

Sector

Industrials

ML Signal

HOLD

Logo Intensity Therapeutics Inc.

INTS

Intensity Therapeutics Inc.

N/A

Current Price

$5.14

Market Cap

13.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AQMS
INTS
Founded
2014
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.8M
13.2M
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
AQMS
INTS
Price
$5.49
$5.14
Analyst Decision
Buy
Buy
Analyst Count
1
3
Target Price
$12.00
$38.00
AVG Volume (30 Days)
47.1K
27.8K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,100,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$600.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.34
$0.19
52 Week High
$39.37
$8.06

Technical Indicators

Market Signals
Indicator
AQMS
INTS
Relative Strength Index (RSI) 71.73 41.61
Support Level $4.58 $5.04
Resistance Level $8.37 $8.06
Average True Range (ATR) 0.34 0.20
MACD 0.13 -0.01
Stochastic Oscillator 92.30 33.53

Price Performance

Historical Comparison
AQMS
INTS

About AQMS Aqua Metals Inc.

Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting, and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.

About INTS Intensity Therapeutics Inc.

Intensity Therapeutics Inc . is a late-stage clinical biotechnology company passionately committed to applying scientific leadership in the field of localized cancer reduction to anti-cancer immune activation. Its new approach involves the direct injection into tumors of a product created from DfuseRxSM discovery platform. Its platform creates patented anti-cancer product candidates comprising active anti-cancer agents and amphiphilic molecules. Its product candidate, INT230-6 comprised of three components: cisplatin, a anti-cancer cytotoxic agent, vinblastine sulfate, also a anti-cancer cytotoxic agent, and an amphiphilic molecule which enables the two cytotoxic agents to disperse through a tumor and diffuse into cancer cells following a direct intratumoral injection.

Share on Social Networks: